Your browser doesn't support javascript.
COVID-19 and immunosuppressive therapy in dermatology.
Schwartz, Robert A; Pradhan, Swetalina; Murrell, Dedee F; Jafferany, Mohammad; Olisova, Olga Y; Lomonosov, Konstantin M; Lotti, Torello; Goldust, Mohamad.
  • Schwartz RA; Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Pradhan S; Department of Dermatology and Venereology, All India Institute of Medical Sciences, Patna, India.
  • Murrell DF; Department of Dermatology, St George Hospital, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Jafferany M; College of Medicine, Central Michigan University, Saginaw, Michigan, USA.
  • Olisova OY; Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Lomonosov KM; Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Lotti T; Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Goldust M; Department of Dermatology, University of Studies Guglielmo Marconi, Rome, Italy.
Dermatol Ther ; 33(6): e14140, 2020 11.
Article in English | MEDLINE | ID: covidwho-696651
ABSTRACT
Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / COVID-19 / Immunosuppressive Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14140

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / COVID-19 / Immunosuppressive Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14140